ASC-SC Antimicrobial Stewardship TeleECHO: Inpatient

Sessions will be held on the 4th Thursday of every month from 12-1pm EST 

Our Goals


Educate and engage with ASPs in community and critical access hospitals


Apply case-based learning to master complex patient and system challenges 


Empower ASPs with tools and resources to improve local antimicrobial use

Benefits of Participation

  • Enhance your antimicrobial stewardship skills
  • Share experiences in the form of case-based discussions
  • Receive specific feedback from panel of experts
  • Implement new stewardship strategies to optimize antimicrobial therapy
  • Improve antimicrobial stewardship metrics at your facility
  • Collaborate with partner hospitals in South Carolina to benefit the entire state population
  • Enhance your understanding of CMS and Joint Commission requirements
  • Earn free CME and CPE credit

For questions, please email:

Click here to enroll.

 Antimicrobial Stewardship TeleECHO Inpatient Curriculum

All times are 12-1pm EST




(UofSC or Prisma Health unless otherwise specified)

March 25, 2021 Gram negative bacteremia: IV to PO transitions Rajivkumar Amipara, MD
April 22, 2021 How can we assess ASPs across hospitals: benchmarking ASP metrics Michihiko Goto, MD, MSCI, FACP (University of Iowa)
May 27, 2021 To treat or not to treat: Acute on chronic wounds Sarah Battle, MD
June 24, 2021 Pancreatitis: when to use antibiotics (and when to not) Brandon Bookstaver, PharmD
July 2021 Summer break!
August 26, 2021 Candidemia bundle Katie Hammer, PharmD (Atrium Health)
September 23, 2021 Got difficult to treat resistance? There is now an antibiotic for that. (New GN antimicrobials) Morgan Pizzuti, PharmD
October 28, 2020 Telehealth Intervention to Reduce Antibiotic Use in Patients with COVID-19 Stephanie Shealy, PharmD (Intermountain Healthcare)

November 18, 2020* (due to holiday)

Cefazolin vs nafcillin for MSSA bacteremia: does it really matter? Vivian Tsai, PharmD

Holiday Break!
January 27, 2022 How to use IT to your advantage with stewardship recommendations Jeannette Bouchard, PharmD
February 24, 2022 Antimicrobial management of SSTI: has linezolid become more cost effective than vancomycin? Utpal Mondal, MBBS